Product Information
EFFEXOR XR 150 MG CAPSULE is a brand product labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., priced at $21.5905 per EA under NDC 00008083621. Its NADAC has been published 657 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the VENLAFAXINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
150 mg/1
NDC
00008083621
Classification
Brand
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
VENLAFAXINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020699On Market Since
11/1/1997
Pharmacological Classes
Price Statistics
The NADAC for EFFEXOR XR 150 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has risen 222.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $21.5905 per EA |
|---|---|
| All-time high | $21.6094 (Jun 10, 2026) |
| All-time low | $6.6869 (Nov 28, 2013) |
| 52-week high | $21.6094 |
| 52-week low | $20.5777 |
| Median price | $16.1750 |
| Average price | $15.2898 |
| Largest weekly change | +9.4% (Jun 8, 2016) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EFFEXOR XR 150 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EFFEXOR XR 150 MG CAPSULE, manufactured by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., is $21.5905 per EA (NDC 00008083621), effective Jun 24, 2026.
How has the price of EFFEXOR XR 150 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EFFEXOR XR 150 MG CAPSULE has risen 222.9%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EFFEXOR XR 150 MG CAPSULE?
Since Nov 28, 2013, the NADAC for EFFEXOR XR 150 MG CAPSULE has ranged from a low of $6.6869 (Nov 28, 2013) to a high of $21.6094 (Jun 10, 2026), with a median of $16.1750 per EA.
Are there cheaper alternatives to EFFEXOR XR 150 MG CAPSULE?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, VENLAFAXINE HCL ER 150 MG CAP, is $0.1169 per EA — about 99% below EFFEXOR XR 150 MG CAPSULE.
Who manufactures EFFEXOR XR 150 MG CAPSULE?
EFFEXOR XR 150 MG CAPSULE (NDC 00008083621) is labeled by Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification